Fischer Medical Ventures Quarterly Results

Latest Quarter Net Profit
₹-12 Cr
QMar 2026
Quarterly Results

Fischer Medical Ventures quarterly results. In Mar 2026, Fischer Medical Ventures (FISCHER) reported revenue ₹98 Cr and net profit ₹-12 Cr — revenue +100.0% YoY. For annual financials, live price and key ratios, visit Fischer Medical Ventures share price chart.

FISCHER Quarterly Results — Revenue, Profit & EPS Highlights

Fischer Medical Ventures latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Also explore Fischer Medical Ventures share price performance to track price trends across different timeframes.

  • Revenue of ₹98 Cr in Mar 2026 (+18.1% vs Jun 2026, +100.0% vs Mar 2025)
  • Net Profit of ₹-12 Cr in Mar 2026 (-400.0% vs Jun 2026, -1300.0% vs Mar 2025)
  • EBITDA of ₹-3 Cr in Mar 2026 (-123.1% vs Jun 2026)
  • Operating Margin of -4.0% in Mar 2026 (-18.0pp vs Jun 2026)
  • Earnings Per Share of ₹-0.19 in Mar 2026 (-416.7% vs Jun 2026)

Fischer Medical Ventures Quarterly Results — Revenue, EBITDA, Net Profit & EPS

FISCHER quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 98 83 89 49 31 18.1% 100.0%
Net Profit (₹ Cr) -12 4 14 1 5 - -
EBITDA (₹ Cr) -3 13 19 3 12 - -
EPS (₹) -0.19 0.06 0.22 -0.05 0.08 - -
Operating Margin (%) -4.0% 14.0% 19.0% 5.0% 17.0% - -

FISCHER Share Price Trend — 1-Year Movement Across Quarterly Results

Fischer Medical Ventures 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. View FISCHER annual price range for the annual high/low range and current price position.

Profitability Ratios

Profit Margin -12.2%
EBITDA Margin -3.1%
Operating Margin -4.0%
ROE (Annual) -12.5%

Balance Sheet Highlights

Total Assets ₹671 Cr
Total Equity ₹385 Cr
Current Assets ₹ Cr
Current Liabilities ₹28 Cr

Cash Flow Analysis

Operating Cash Flow ₹-101 Cr
Investing Cash Flow ₹-5 Cr
Financing Cash Flow ₹14 Cr
Net Cash Flow ₹-92 Cr

Current Market Data

Current Price ₹22.86
Exchange NSE
Last Updated Nov 19, 2026

FISCHER vs Chemicals Peers — Quarterly Revenue, Profit & Market Cap

Fischer Medical Ventures latest quarter revenue and net profit vs Chemicals competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Solar Industries
Sept 2026
₹170,302.28 Cr 18850.0 3,534 650 +14.0% - 18.4% 276.4
Pidilite Industries
Sept 2026
₹155,755.95 Cr 1580.5 4,367 627 +19.7% - 14.4% 261.7
SRF
Sept 2026
₹72,475.87 Cr 2513.9 4,828 509 +5.9% - 10.5% 146.3
Linde
Sept 2026
₹58,423.96 Cr 6742.0 734 119 +18.2% - 16.2% 484.0
Coromandel Internat…
Sept 2026
₹57,802.43 Cr 1972.0 10,348 523 +70.5% - 5.1% 108.7
Sector Quarterly Performance Comparison
Chemicals sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores